Table 1.

Human brain tissue used for QC and pE-Aβ labellings

Case #	PMD (h)	Gender	Age (years)	Brain weight (g)	COD	Braak staging
Control
1	48	Female	75	1,130	Cardial infarction	0
2	72	Female	68	1,284	Bronchopneumonia	0
3	24	Female	82	1,180	Ovarian cancer	0
4	48	Male	78	1,420	Cardial infarction	0
5	9	Female	43	n.a.	Drug overd. (insulin)	0
6	24	Female	80	1,190	Lung cancer	0
7	25	Female	75	1,234	Lung cancer	0
8	7	Male	78	1,394	Pulmonary failure	0
Mean	32.1	6/2	72.4
AD
1	55	Female	95	1,060	Cardial infarction	VI
2	32	Female	70	1,200	Respiratory failure	IV
3	28	Male	68	960	Bronchopneumonia	VI
4	6	Female	58	1,010	Respiratory failure	IV
5	16	Female	65	1,080	Respiratory failure	V
6	40	Female	79	1,006	n.a.	IV
7	24	Male	69	934	n.a.	V
8	42	Female	91	1,230	Stroke	IV
Mean	30.4	6/2	74.4

AD Alzheimer’s disease, PMD postmortem delay, COD cause of death, EC entorhinal cortex